Opana ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals, Inc.. The primary component is Oxymorphone Hydrochloride.
| Product ID | 63481-814_78824d02-9c7b-45ce-8030-48bc1d817cc6 | 
| NDC | 63481-814 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Opana ER | 
| Generic Name | Oxymorphone Hydrochloride | 
| Dosage Form | Tablet, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-03-20 | 
| Marketing End Date | 2020-01-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA201655 | 
| Labeler Name | Endo Pharmaceuticals, Inc. | 
| Substance Name | OXYMORPHONE HYDROCHLORIDE | 
| Active Ingredient Strength | 10 mg/1 | 
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] | 
| DEA Schedule | CII | 
| NDC Exclude Flag | N | 
| Marketing Start Date | 2012-03-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA201655 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-03-20 | 
| Marketing End Date | 2012-03-20 | 
| Marketing Category | NDA | 
| Application Number | NDA201655 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-03-20 | 
| Marketing End Date | 2014-10-31 | 
| Marketing Category | NDA | 
| Application Number | NDA201655 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-03-20 | 
| Marketing End Date | 2020-01-01 | 
| Ingredient | Strength | 
|---|---|
| OXYMORPHONE HYDROCHLORIDE | 10 mg/1 | 
| SPL SET ID: | e6e34c18-fbc6-4cab-9aed-0905d93c2ab6 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 21695-948 | OPANA ER | OPANA ER | 
| 21695-949 | OPANA ER | OPANA ER | 
| 35356-825 | Opana ER | Opana ER | 
| 35356-848 | Opana ER | Opana ER | 
| 35356-849 | Opana ER | Opana ER | 
| 35356-820 | Opana ER | Opana ER | 
| 63481-816 | Opana ER | Opana ER | 
| 63481-817 | Opana ER | Opana ER | 
| 63481-814 | Opana ER | Opana ER | 
| 63481-815 | Opana ER | Opana ER | 
| 63481-818 | Opana ER | Opana ER | 
| 63481-812 | Opana ER | Opana ER | 
| 63481-813 | Opana ER | Opana ER | 
| 63629-4174 | Opana ER | Opana ER | 
| 63629-4177 | OPANA ER | OPANA ER | 
| 0054-0283 | Oxymorphone Hydrochloride | oxymorphone hydrochloride | 
| 0054-0284 | Oxymorphone Hydrochloride | oxymorphone hydrochloride | 
| 0115-1231 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1232 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1233 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1234 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1315 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1316 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
| 0115-1317 | Oxymorphone hydrochloride | Oxymorphone hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() OPANA  77471861  3553676 Dead/Cancelled  | 
        Endo Pharmaceuticals Inc.  2008-05-12  | 
![]() OPANA  77471835  3585918 Dead/Cancelled  | 
        Endo Pharmaceuticals Inc.  2008-05-12  | 
![]() OPANA  76665614  3252736 Dead/Cancelled  | 
        Endo Pharmaceuticals Inc.  2006-09-05  | 
![]() OPANA  76478457  3060635 Live/Registered  | 
        Endo Pharmaceuticals Inc.  2002-12-20  |